SIStemA |
| hESC | Human Embryonic Stem Cells |
| hiPSC | Human Induced Pluripotent Stem Cells |
| LGE | Lateral Ganglionic Eminence |
| MGE | Medial Ganglionic Eminence |
| MSC | Mesenchymal Stem Cells |
| NSC | Neural Stem Cells |
| RPE | Retinal Pigment Epithelium |
| ATRA | Hutchinson-Gilford syndrome | ORPHA:740 |
| DM1 | Myotonic Dystrophy type I | ORPHA:273 |
| DMD | Duchenne Muscular Dystrophy | ORPHA:98896 |
| EB | Epidermolysis bullosa | ORPHA:304 |
| HD | Huntington disease | ORPHA:399 |
| LND | Lesch Nyhan Disease | ORPHA:510 |
| SMA | Spinal muscular atrophy | ORPHA:83330 |
| WFS | Wolfram Syndrome | ORPHA:3463 |
| WT | Non affected | |
| E3 | CRISPR MBNL1 (-/-) | |
| H4 | CRISPR MBNL1 (-/-) MBNL2 (-/-) |
| DIV | Day In Vitro: number of day in vitro culture after differentiation and before collection of the sample |
| P | Passage: term representing the number of passage before the hESC/hIPSC sample is collected or used for differentiation. Depending on the cell line, a passage corresponds to 5 or 7 days |
| KO | Gene Knock-Out, cells with a loss-of-function mutation in a gene. |
| KI | Gene Knock-In |
| MEF | Mouse Embryonic Fibroblasts |
| PO | Poly-L-Ornithine |
| LAM | Laminine |
| FB | Fibronectine |
| GFP | Green Fluorescent protein |